Firm News: Drugs & Devices: Page 15

A former Accutane user was awarded $9 million by a New Jersey jury against Hoffmann La-Roche Inc. and Roche Laboratories, subsidiaries of Roche Holding AG (ROG). The pharmaceutical companies are based in Nutley, N.J. The plaintiff, one of four in a combined trial, took Accutane for acne treatment from 1997-1998 when she was a teenager. …

Weitz & Luxenberg P.C. has announced that Ellen Relkin will serve as a presenter at the June 28, 2010 Mass Torts Judicial Forum in Philadelphia, Pennsylvania. Ms. Relkin will participate in a discussion on expert witness testimony and medical causation proofs in this one-day seminar that includes presentations from a number of leading mass-tort judges…

Weitz & Luxenberg P.C. would like to inform patients of a debilitating condition, postarthroscopic glenohumeral chondrolysis (PAGCL), which results in the permanent degeneration of shoulder cartilage. This devastating and painful process has been linked to a post-surgical treatment for shoulder pain that has been performed across the country. Pain pumps are used to manage post-operative…

Weitz & Luxenberg P.C. would like to inform the public that the Food and Drug Administration (FDA) issued a warning on May 1, 2009 to immediately stop use of Hydroxycut dietary supplements by Iovate Health Sciences Inc. after reports of serious health problems in users taking the recommended doses. Iovate recalled 14 Hydroxycut products from…

Weitz & Luxenberg client John McDarby, 77, and his wife were rewarded a $4.5 million dollar verdict and $9 million in punitive damages from a New Jersey jury in one of the first Vioxx trial cases against Merck. ”The verdict is a victory for the 100,000 Americans who had heart attacks from Vioxx,” said lawyer Robert Gordon.…